Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Abivax S.a.

Clinical trials sponsored by Abivax S.a., explained in plain language.

Abivax S.A. ABVX NASDAQ

Biotech developing treatments for inflammatory diseases and viral infections.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 2 Completed 5 Terminated 1

Experimental COVID-19 drug fails to prevent respiratory failure in High-Risk patients

Disease control Terminated

This study tested an experimental drug called ABX464 in 509 high-risk COVID-19 patients aged 65 and older, or those 18+ with risk factors like obesity or diabetes. The goal was to see if the drug could reduce inflammation and prevent the need for high-flow oxygen or a breathing m…

Phase: PHASE2, PHASE3 • Sponsor: Abivax S.A. • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC